Adipokine profiles and genetic variants of leptin receptor, adiponectin, and ghrelin pathways in obesity: prospective 12-month outcomes after bariatric interventions - Scorecard - MDSpire

Adipokine profiles and genetic variants of leptin receptor, adiponectin, and ghrelin pathways in obesity: prospective 12-month outcomes after bariatric interventions

  • By

  • Andriy Prodan

  • Ihor Dzyubanovsky

  • Iryna Halabitska

  • Pavlo Petakh

  • Iryna Kamyshna

  • Oleksandr Kamyshnyi

  • May 20, 2026

  • 0 min

Share

Clinical Scorecard: Genetic Variants and Adipokine Levels in Obesity: A 12-Month Follow-Up Study Post-Bariatric Surgery

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationAdult patients with varying degrees of obesity undergoing different types of bariatric surgery
Care Setting

Key Highlights

  • Genetic variants significantly influence hormonal changes and weight loss outcomes post-surgery.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • Evaluate changes in adipokine levels, BMI, and glycemic control post-surgery.

      Risks

        Patient & Prescribing Data

        Bariatric surgery (including endovascular embolization, gastroplication, or sleeve gastrectomy) effectively normalizes hormonal profiles and improves metabolic outcomes.

        Clinical Best Practices

        • Integrate genetic testing to personalize obesity treatment plans.
        • Monitor hormonal profiles and metabolic parameters post-bariatric surgery, with follow-ups every 3 months for the first year.

        Related Resources & Content

        Original Source(s)

        Adipokine profiles and genetic variants of leptin receptor, adiponectin, and ghrelin pathways in obesity: prospective 12-month outcomes after bariatric interventions

        • by Andriy Prodan, Ihor Dzyubanovsky, Iryna Halabitska, Pavlo Petakh, Iryna Kamyshna, Oleksandr Kamyshnyi

        • May 20, 2026

        Related Content

        Combination Therapy Shows Potential in Psoriasis, Obesity

        Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

        Side Effects: They Googled It

        Patients are mining Reddit and TikTok for symptom intel while you're not — and a small study calls it epistemic injustice. Different knowledge, mutually unrecognized. Maybe ask where they've been reading before you wave it off as anecdote.

        Lipidomics Point to Obesity–Alzheimer's Link

        Study uses multi-omics tools to examine obesity-related pathways linked to neurodegeneration

        • May 26, 2026

        • 2 min